DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,556,751 | +3.6% | 34,507 | +0.2% | 2.53% | +2.0% |
| Q2 2023 | $8,262,960 | -5.1% | 34,429 | -0.3% | 2.48% | -13.5% |
| Q1 2023 | $8,705,462 | -7.0% | 34,540 | -2.0% | 2.86% | -11.7% |
| Q4 2022 | $9,358,709 | +1.7% | 35,260 | -1.0% | 3.24% | -5.8% |
| Q3 2022 | $9,198,000 | +0.8% | 35,613 | -1.1% | 3.44% | +6.1% |
| Q2 2022 | $9,125,000 | -16.1% | 35,994 | -2.9% | 3.25% | +2.2% |
| Q1 2022 | $10,875,000 | -11.5% | 37,075 | -0.8% | 3.18% | -4.2% |
| Q4 2021 | $12,295,000 | +5.1% | 37,369 | -2.8% | 3.32% | -3.8% |
| Q3 2021 | $11,703,000 | +13.2% | 38,441 | -0.2% | 3.45% | +9.7% |
| Q2 2021 | $10,334,000 | +20.1% | 38,507 | +0.7% | 3.14% | +5.8% |
| Q1 2021 | $8,606,000 | -0.6% | 38,234 | -1.9% | 2.97% | -5.3% |
| Q4 2020 | $8,661,000 | +20.6% | 38,987 | -4.0% | 3.14% | +0.8% |
| Q2 2020 | $7,180,000 | +21.8% | 40,602 | -4.7% | 3.11% | +1.1% |
| Q1 2020 | $5,897,000 | -10.2% | 42,605 | -0.4% | 3.08% | +13.9% |
| Q4 2019 | $6,565,000 | +6.0% | 42,772 | -0.2% | 2.70% | -1.0% |
| Q3 2019 | $6,193,000 | +0.6% | 42,878 | -0.4% | 2.73% | -1.2% |
| Q2 2019 | $6,154,000 | +7.9% | 43,056 | -0.4% | 2.76% | -4.0% |
| Q1 2019 | $5,706,000 | +28.3% | 43,222 | +0.2% | 2.88% | +5.2% |
| Q4 2018 | $4,447,000 | -5.1% | 43,120 | 0.0% | 2.73% | +11.7% |
| Q3 2018 | $4,685,000 | +9.9% | 43,120 | -0.2% | 2.45% | -1.8% |
| Q2 2018 | $4,263,000 | -0.5% | 43,202 | -1.3% | 2.49% | -3.8% |
| Q1 2018 | $4,286,000 | -2.5% | 43,775 | -1.0% | 2.59% | +11.5% |
| Q4 2017 | $4,394,000 | +8.8% | 44,210 | -0.6% | 2.32% | +5.0% |
| Q3 2017 | $4,037,000 | +9.2% | 44,470 | -0.0% | 2.21% | -1.2% |
| Q2 2017 | $3,696,000 | -4.0% | 44,472 | -1.3% | 2.24% | -3.3% |
| Q1 2017 | $3,852,000 | +3.0% | 45,042 | -2.2% | 2.32% | -4.3% |
| Q4 2016 | $3,738,000 | +6.4% | 46,069 | +1.8% | 2.42% | +5.9% |
| Q3 2016 | $3,513,000 | -13.7% | 45,249 | +12.2% | 2.29% | -16.9% |
| Q2 2016 | $4,072,000 | +0.0% | 40,316 | -6.1% | 2.75% | -10.0% |
| Q1 2016 | $4,071,000 | -1.7% | 42,916 | -3.7% | 3.05% | -2.3% |
| Q4 2015 | $4,141,000 | +7.3% | 44,586 | -1.6% | 3.12% | +2.8% |
| Q3 2015 | $3,861,000 | -5.6% | 45,306 | -5.2% | 3.04% | +10.7% |
| Q2 2015 | $4,089,000 | +0.6% | 47,778 | -0.2% | 2.75% | +1.2% |
| Q1 2015 | $4,066,000 | -1.5% | 47,893 | -0.5% | 2.72% | -5.3% |
| Q4 2014 | $4,126,000 | +12.5% | 48,138 | -0.3% | 2.87% | +7.7% |
| Q3 2014 | $3,668,000 | -4.3% | 48,278 | -0.9% | 2.66% | -1.8% |
| Q2 2014 | $3,834,000 | +2.8% | 48,698 | -2.1% | 2.71% | -1.1% |
| Q1 2014 | $3,730,000 | -4.2% | 49,731 | -1.3% | 2.74% | -1.4% |
| Q4 2013 | $3,892,000 | +10.9% | 50,411 | -0.4% | 2.78% | +0.1% |
| Q3 2013 | $3,509,000 | +10.6% | 50,616 | +1.0% | 2.78% | +1.8% |
| Q2 2013 | $3,173,000 | – | 50,125 | – | 2.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |